Pune, India

Ramesh Ananda Mokal

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Hikal Limited. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramesh Ananda Mokal. Retrieved from https://idiyas.com/inventor/ramesh-ananda-mokal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ramesh Ananda Mokal: Innovator in Pharmaceutical Chemistry

Introduction

Ramesh Ananda Mokal is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for synthesizing important compounds.

Latest Patents

Ramesh Mokal holds a patent for a process for the preparation of pregabalin. This innovative process involves several steps, including the reaction of isovaleraldehyde and alkyl cyanoacetate, leading to the synthesis of racemic 3-cyano-5-methyl-hexanoic acid. The patent outlines a detailed methodology that includes enzymatic hydrolysis and hydrogenation to produce the final compound, pregabalin.

Career Highlights

Ramesh Mokal is currently employed at Hikal Limited, where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the company's research and development initiatives.

Collaborations

He has collaborated with colleagues such as Swapnil Surendra Mohile and Swapnil Gulabrao Yerande, contributing to a dynamic team focused on innovative solutions in the pharmaceutical industry.

Conclusion

Ramesh Ananda Mokal's contributions to the field of pharmaceutical chemistry, particularly through his patent for the preparation of pregabalin, highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…